SEC Filing Summary for BioStem Technologies, Inc.

This filing details the ownership changes and holdings of Michael Fortunato, Chief Accounting Officer of BioStem Technologies, Inc. It includes information on stock options and restricted stock units (RSUs) with various vesting schedules and exercise prices. Specifically, there are vested and unvested stock options with exercise prices ranging from $1.07 to $15.11, and expiration dates extending to 2035. The filing also reports on RSUs, which represent contingent rights to shares of common stock, with vesting schedules spread over several years. Mr. Fortunato directly owns 63,460 shares of BioStem Technologies, Inc. common stock following these transactions. The report was signed on August 14, 2026.